Page last updated: 2024-08-26

1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine and n(6)-cyclohexyladenosine

1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine has been researched along with n(6)-cyclohexyladenosine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobson, KA; van Galen, PJ; Williams, M1
Braunwalder, A; Cash, WD; Francis, J; Ghai, G; Psychoyos, S; Stone, GA; Williams, M1
Braunwalder, A; Ferkany, JW; Jarvis, MF; Sills, MA; Williams, M1
Braunwalder, A; Erickson, TJ; Williams, M1
Jarrott, B; Krstew, E; Lawrence, AJ2

Reviews

1 review(s) available for 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine and n(6)-cyclohexyladenosine

ArticleYear
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
    Journal of medicinal chemistry, 1992, Feb-07, Volume: 35, Issue:3

    Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship

1992

Other Studies

5 other study(ies) available for 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine and n(6)-cyclohexyladenosine

ArticleYear
Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Brain; Guinea Pigs; Kinetics; Neurotransmitter Agents; Pyrazoles; Quinazolines; Rats; Receptors, Purinergic; Triazoles; Xanthines

1987
Biochemical characterization of the antagonist actions of the xanthines, PACPX (1,3-dipropyl-8(2-amino-4-chloro)phenylxanthine) and 8-PT (8-phenyltheophylline) at adenosine A1 and A2 receptors in rat brain tissue.
    Biochemical pharmacology, 1987, Nov-15, Volume: 36, Issue:22

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain; In Vitro Techniques; Kinetics; Rats; Receptors, Purinergic; Theophylline; Xanthines

1987
Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue.
    Naunyn-Schmiedeberg's archives of pharmacology, 1986, Volume: 332, Issue:2

    Topics: Adenosine; Animals; Brain; Kinetics; Membranes; Phenylisopropyladenosine; Purine Nucleotides; Pyrazoles; Rats; Xanthines

1986
Complex interactions between nitric oxide and adenosine receptors in the rat isolated nodose ganglion.
    European journal of pharmacology, 1997, Jun-05, Volume: 328, Issue:1

    Topics: Adenosine; Animals; Antineoplastic Agents; Diethylamines; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiology; In Vitro Techniques; Male; Neurons, Afferent; Nitric Oxide; Nodose Ganglion; Norbornanes; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Vagus Nerve; Xanthines

1997
Autoradiographic visualisation of axonal transport of adenosine A1 receptors along the rat vagus nerve and characterisation of adenosine A1 receptor binding in the dorsal vagal complex of hypertensive and normotensive rats.
    Brain research, 1998, Aug-17, Volume: 802, Issue:1-2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Autoradiography; Axonal Transport; Binding, Competitive; Hypertension; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Purinergic P1; Reference Values; Solitary Nucleus; Vagus Nerve; Xanthines

1998